Proactiveinvestors Australia Benitec Biopharma https://www.proactiveinvestors.com.au Proactiveinvestors Australia Benitec Biopharma RSS feed en Sun, 08 Dec 2019 17:39:48 +1100 http://blogs.law.harvard.edu/tech/rss Genera CMS action@proactiveinvestors.com (Proactiveinvestors) action@proactiveinvestors.com (Proactiveinvestors) Benitec Biopharma begins phase II clinical study for head and neck cancer treatment https://www.proactiveinvestors.com.au/companies/news/192571/benitec-biopharma-begins-phase-ii-clinical-study-for-head-and-neck-cancer-treatment-192571.html Mon, 05 Mar 2018 02:30:00 +1100 https://www.proactiveinvestors.com.au/companies/news/192571/benitec-biopharma-begins-phase-ii-clinical-study-for-head-and-neck-cancer-treatment-192571.html Benitec Biopharma’s shares ride higher after securing new U.S. patent https://www.proactiveinvestors.com.au/companies/news/185817/benitec-biopharmas-shares-ride-higher-after-securing-new-us-patent-185817.html Wed, 18 Oct 2017 21:41:00 +1100 https://www.proactiveinvestors.com.au/companies/news/185817/benitec-biopharmas-shares-ride-higher-after-securing-new-us-patent-185817.html Benitec Biopharma receives $5.59M to advance gene silencing tech https://www.proactiveinvestors.com.au/companies/news/175338/benitec-biopharma-receives-559m-to-advance-gene-silencing-tech-175338.html Fri, 24 Mar 2017 04:00:00 +1100 https://www.proactiveinvestors.com.au/companies/news/175338/benitec-biopharma-receives-559m-to-advance-gene-silencing-tech-175338.html Benitec Biopharma receives orphan drug designation in Europe https://www.proactiveinvestors.com.au/companies/news/171694/benitec-biopharma-receives-orphan-drug-designation-in-europe-171694.html Mon, 16 Jan 2017 22:00:00 +1100 https://www.proactiveinvestors.com.au/companies/news/171694/benitec-biopharma-receives-orphan-drug-designation-in-europe-171694.html Benitec Biopharma Ltd is Wednesday's ASX % Gainer intra-day https://www.proactiveinvestors.com.au/companies/news/150379/benitec-biopharma-ltd-is-wednesdays-asx-gainer-intra-day-69925.html Wed, 20 Jul 2016 03:30:00 +1000 https://www.proactiveinvestors.com.au/companies/news/150379/benitec-biopharma-ltd-is-wednesdays-asx-gainer-intra-day-69925.html Benitec Biopharma Ltd has Hepatitis B success with treatment https://www.proactiveinvestors.com.au/companies/news/150377/benitec-biopharma-ltd-has-hepatitis-b-success-with-treatment-67395.html Tue, 08 Mar 2016 07:37:00 +1100 https://www.proactiveinvestors.com.au/companies/news/150377/benitec-biopharma-ltd-has-hepatitis-b-success-with-treatment-67395.html Benitec Biopharma readies to raise cash https://www.proactiveinvestors.com.au/companies/news/150373/benitec-biopharma-readies-to-raise-cash-64049.html Tue, 18 Aug 2015 05:00:00 +1000 https://www.proactiveinvestors.com.au/companies/news/150373/benitec-biopharma-readies-to-raise-cash-64049.html Benitec Biopharma advancing muscle disease treatment to clinic https://www.proactiveinvestors.com.au/companies/news/150371/benitec-biopharma-advancing-muscle-disease-treatment-to-clinic-63271.html Fri, 03 Jul 2015 03:30:00 +1000 https://www.proactiveinvestors.com.au/companies/news/150371/benitec-biopharma-advancing-muscle-disease-treatment-to-clinic-63271.html Benitec Biopharma signs manufacturing deal for hepatitis C treatment https://www.proactiveinvestors.com.au/companies/news/150369/benitec-biopharma-signs-manufacturing-deal-for-hepatitis-c-treatment-62559.html Mon, 25 May 2015 04:30:00 +1000 https://www.proactiveinvestors.com.au/companies/news/150369/benitec-biopharma-signs-manufacturing-deal-for-hepatitis-c-treatment-62559.html Benitec Biopharma continues clinical trial for hepatitis C treatment https://www.proactiveinvestors.com.au/companies/news/150367/benitec-biopharma-continues-clinical-trial-for-hepatitis-c-treatment-61197.html Wed, 11 Mar 2015 05:30:00 +1100 https://www.proactiveinvestors.com.au/companies/news/150367/benitec-biopharma-continues-clinical-trial-for-hepatitis-c-treatment-61197.html Benitec Biopharma continues clinical trial for hepatitis C treatment https://www.proactiveinvestors.com.au/companies/news/150365/benitec-biopharma-continues-clinical-trial-for-hepatitis-c-treatment-59948.html Wed, 07 Jan 2015 05:00:00 +1100 https://www.proactiveinvestors.com.au/companies/news/150365/benitec-biopharma-continues-clinical-trial-for-hepatitis-c-treatment-59948.html Benitec Biopharma queried by ASX https://www.proactiveinvestors.com.au/companies/news/150363/benitec-biopharma-queried-by-asx-58863.html Tue, 11 Nov 2014 07:00:00 +1100 https://www.proactiveinvestors.com.au/companies/news/150363/benitec-biopharma-queried-by-asx-58863.html Benitec Biopharma raises first tranche of $15.75M to accelerate development of clinical treatments https://www.proactiveinvestors.com.au/companies/news/150361/benitec-biopharma-raises-first-tranche-of-1575m-to-accelerate-development-of-clinical-treatments-53301.html Fri, 28 Feb 2014 07:20:00 +1100 https://www.proactiveinvestors.com.au/companies/news/150361/benitec-biopharma-raises-first-tranche-of-1575m-to-accelerate-development-of-clinical-treatments-53301.html Benitec Biopharma to bank up to $31.5 million for Hepatitis C treatment https://www.proactiveinvestors.com.au/companies/news/150358/benitec-biopharma-to-bank-up-to-315-million-for-hepatitis-c-treatment-53105.html Mon, 24 Feb 2014 03:00:00 +1100 https://www.proactiveinvestors.com.au/companies/news/150358/benitec-biopharma-to-bank-up-to-315-million-for-hepatitis-c-treatment-53105.html Benitec Biopharma's shares take-off https://www.proactiveinvestors.com.au/companies/news/150356/benitec-biopharmas-shares-take-off-53096.html Mon, 24 Feb 2014 00:20:00 +1100 https://www.proactiveinvestors.com.au/companies/news/150356/benitec-biopharmas-shares-take-off-53096.html Benitec Biopharma responds to ASX price query; shares spike https://www.proactiveinvestors.com.au/companies/news/150354/benitec-biopharma-responds-to-asx-price-query-shares-spike-53046.html Fri, 21 Feb 2014 02:30:00 +1100 https://www.proactiveinvestors.com.au/companies/news/150354/benitec-biopharma-responds-to-asx-price-query-shares-spike-53046.html Benitec Biopharma to seek US regulatory nod to start Hepatitis C drug trial https://www.proactiveinvestors.com.au/companies/news/150351/benitec-biopharma-to-seek-us-regulatory-nod-to-start-hepatitis-c-drug-trial-40582.html Fri, 08 Mar 2013 04:20:00 +1100 https://www.proactiveinvestors.com.au/companies/news/150351/benitec-biopharma-to-seek-us-regulatory-nod-to-start-hepatitis-c-drug-trial-40582.html Benitec Biopharma to raise funds https://www.proactiveinvestors.com.au/companies/news/150349/benitec-biopharma-to-raise-funds-39983.html Mon, 25 Feb 2013 02:20:00 +1100 https://www.proactiveinvestors.com.au/companies/news/150349/benitec-biopharma-to-raise-funds-39983.html Benitec Biopharma makes breakthrough in gene silencing to treat muscular dystrophy https://www.proactiveinvestors.com.au/companies/news/150346/benitec-biopharma-makes-breakthrough-in-gene-silencing-to-treat-muscular-dystrophy-36730.html Mon, 03 Dec 2012 04:40:00 +1100 https://www.proactiveinvestors.com.au/companies/news/150346/benitec-biopharma-makes-breakthrough-in-gene-silencing-to-treat-muscular-dystrophy-36730.html Benitec Biopharma' lung cancer treatment delivers positive results https://www.proactiveinvestors.com.au/companies/news/150344/benitec-biopharma-lung-cancer-treatment-delivers-positive-results-35786.html Tue, 13 Nov 2012 02:10:00 +1100 https://www.proactiveinvestors.com.au/companies/news/150344/benitec-biopharma-lung-cancer-treatment-delivers-positive-results-35786.html Benitec Biopharma acquires U.S. based Tacere Therapeutics https://www.proactiveinvestors.com.au/companies/news/150342/benitec-biopharma-acquires-us-based-tacere-therapeutics-35135.html Tue, 30 Oct 2012 02:00:00 +1100 https://www.proactiveinvestors.com.au/companies/news/150342/benitec-biopharma-acquires-us-based-tacere-therapeutics-35135.html Benitec Biopharma set to benefit from European Regulator's gene therapy decision https://www.proactiveinvestors.com.au/companies/news/150340/benitec-biopharma-set-to-benefit-from-european-regulators-gene-therapy-decision--31579.html Mon, 23 Jul 2012 04:00:00 +1000 https://www.proactiveinvestors.com.au/companies/news/150340/benitec-biopharma-set-to-benefit-from-european-regulators-gene-therapy-decision--31579.html Benitec Biopharma One2One Investor Presentation 18 July 2012 https://www.proactiveinvestors.com.au/companies/news/305630/benitec-biopharma-one2one-investor-presentation-18-july-2012-255.html Wed, 18 Jul 2012 06:44:00 +1000 https://www.proactiveinvestors.com.au/companies/news/305630/benitec-biopharma-one2one-investor-presentation-18-july-2012-255.html Benitec Biopharma signs key genetic eye disease licensing agreement with Genable Technologies https://www.proactiveinvestors.com.au/companies/news/150338/benitec-biopharma-signs-key-genetic-eye-disease-licensing-agreement-with-genable-technologies-31096.html Tue, 10 Jul 2012 02:30:00 +1000 https://www.proactiveinvestors.com.au/companies/news/150338/benitec-biopharma-signs-key-genetic-eye-disease-licensing-agreement-with-genable-technologies-31096.html Benitec Biopharma to discuss move towards human trials of gene silencing technology in Sydney https://www.proactiveinvestors.com.au/companies/news/150336/benitec-biopharma-to-discuss-move-towards-human-trials-of-gene-silencing-technology-in-sydney--30943.html Thu, 05 Jul 2012 22:20:00 +1000 https://www.proactiveinvestors.com.au/companies/news/150336/benitec-biopharma-to-discuss-move-towards-human-trials-of-gene-silencing-technology-in-sydney--30943.html Benitec Biopharma moves towards human clinical studies for HIV/AIDS and Hepatitis C https://www.proactiveinvestors.com.au/companies/news/150333/benitec-biopharma-moves-towards-human-clinical-studies-for-hivaids-and-hepatitis-c-30331.html Tue, 19 Jun 2012 22:30:00 +1000 https://www.proactiveinvestors.com.au/companies/news/150333/benitec-biopharma-moves-towards-human-clinical-studies-for-hivaids-and-hepatitis-c-30331.html Benitec Biopharma’s gene silencing technology trialled in cancer vaccine https://www.proactiveinvestors.com.au/companies/news/150332/benitec-biopharmas-gene-silencing-technology-trialled-in-cancer-vaccine-23981.html Tue, 10 Jan 2012 04:48:00 +1100 https://www.proactiveinvestors.com.au/companies/news/150332/benitec-biopharmas-gene-silencing-technology-trialled-in-cancer-vaccine-23981.html Benitec Biopharma hepatitis C therapeutic pre-clinical results released https://www.proactiveinvestors.com.au/companies/news/150330/benitec-biopharma-hepatitis-c-therapeutic-pre-clinical-results-released-23924.html Mon, 09 Jan 2012 03:01:00 +1100 https://www.proactiveinvestors.com.au/companies/news/150330/benitec-biopharma-hepatitis-c-therapeutic-pre-clinical-results-released-23924.html Benitec endorsement of Pain Program from US and European clinical pain specialists https://www.proactiveinvestors.com.au/companies/news/150328/benitec-endorsement-of-pain-program-from-us-and-european-clinical-pain-specialists-19803.html Mon, 19 Sep 2011 22:02:00 +1000 https://www.proactiveinvestors.com.au/companies/news/150328/benitec-endorsement-of-pain-program-from-us-and-european-clinical-pain-specialists-19803.html Benitec gene silencing technology shows potential in development of prostate cancer treatment https://www.proactiveinvestors.com.au/companies/news/150326/benitec-gene-silencing-technology-shows-potential-in-development-of-prostate-cancer-treatment-16732.html Tue, 31 May 2011 06:21:00 +1000 https://www.proactiveinvestors.com.au/companies/news/150326/benitec-gene-silencing-technology-shows-potential-in-development-of-prostate-cancer-treatment-16732.html Benitec granted RNA interference patent for Hepatitis C in Japan https://www.proactiveinvestors.com.au/companies/news/150325/benitec-granted-rna-interference-patent-for-hepatitis-c-in-japan-16570.html Wed, 25 May 2011 02:15:00 +1000 https://www.proactiveinvestors.com.au/companies/news/150325/benitec-granted-rna-interference-patent-for-hepatitis-c-in-japan-16570.html